DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.message sent
email sent successfully
| You are receiving this because you have an account on www.oneGRAVESvoice.com | ||
| To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
International Thyroid Eye Disease Society International Symposium
The International Thyroid Eye Disease Society (ITEDS) Symposium will come to Asia for the first time and it will be held in Singapore. Themed “Current Perspectives in the Management of Thyroid Eye Disease: East Meets West”, all segments of the Symposium will be helmed by world-renowned experts specially gathered to share their expertise and years of experience. They will cover all aspects of Thyroid Eye Disease and there will be something for everyone: the medical student, allied health specialist, physician, endocrinologist, ophthalmologist and orbit surgeon.
When:
February 20-23, 2019
Where:
Academia
Singapore General Hospital (SGH) Campus
20 College Road, Singapore.
The event has ended.
myBinderRelated Content
-
Evidence & EducationAnatomic Considerations in Thyroid Eye DiseasePurpose: To review and summarize the cl...
-
Evidence & EducationRandomized Controlled Trial of Rituximab in Patients With Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
-
Evidence & EducationEarly Use of Steroid-Sparing Agents in the Inactivation of Moderate-to-Severe Active Thyroid eye DiseaseObjectives: The current first-line trea...
-
Evidence & EducationEfficacy and Safety of Immunosuppressive Agents for Thyroid Eye DiseasePurpose: To present an update on the ef...
-
News & MeetingsLatin American Thyroid Society CongressThe XIX Latin American Thyroid Society C...
-
News & MeetingsFDA Approves First Treatment for Thyroid Eye Disease (Teprotumumab)The U.S. Food and Drug Administration (F...
-
Videos & VisualsWarning Signs of Graves’ Disease and Thyroid Eye Diseasehttps://mms.businesswire.com/media/20190...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.